Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights
T'Cher Trial Summary
This trial aims to improve PrEP use and adherence among trans women, to help protect them from HIV. #PrEP #transhealth
Who is the study for?
This trial is for trans women over 18 living in the New Orleans area who want to start or restart PrEP, a medication that prevents HIV. Participants must not be infected with HIV, agree to study procedures, and attend quarterly visits. They cannot join if they're in another PrEP study or have conditions affecting consent or safety.Check my eligibility
What is being tested?
The trial tests a Peer PrEP Navigation program aimed at increasing uptake and adherence to PrEP among trans women. It's a single arm stepped wedge design comparing outcomes of participants receiving the intervention immediately versus those with delayed access.See study design
What are the potential side effects?
Since this trial focuses on peer navigation rather than a medical intervention, traditional side effects are not applicable. However, there may be social or psychological impacts from participating in the program which will be monitored.
T'Cher Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 24 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Health care empowerment
PrEP uptake
Social determinant stressors
Secondary outcome measures
Patterns and correlates of PrEP adherence
T'Cher Trial Design
1Treatment groups
Experimental Treatment
Group I: PrEP peer navigationExperimental Treatment1 Intervention
Culturally informed health care empowerment and PrEP peer navigation and support through social determinant of health stressors
Find a Location
Who is running the clinical trial?
CrescentCareLead Sponsor
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.I was designated male at birth.I am willing to attend follow-up visits every three months and participate in surveys.I do not have HIV.I identify as a trans woman, woman, or a gender other than man.I speak English or Spanish.I want to start or resume using PrEP.
Research Study Groups:
This trial has the following groups:- Group 1: PrEP peer navigation
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research endeavor recruiting participants?
"As per the data hosted on clinicaltrials.gov, this research endeavour is no longer open for recruitment. It was posted on January 31st 2023 and last updated on January 17th 2023. Despite not actively recruiting participants anymore, there are still 89 other studies looking to enroll individuals at present time."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger